Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

2,2-dimethylbutyric acid, sodium salt

EU orphan designation number: EU/3/09/621   
Active ingredient: 2,2-dimethylbutyric acid, sodium salt
Indication: Treatment of sickle cell disease
Sponsor: Isabelle Ramirez
Friedrichstraße 5 , D-12205 Berlin, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/03/2009 Centralised Orphan - Designation EMEA/OD/107/08 (2009)2096 of 18/03/2009